Turner syndrome (TS) leads to various abnormalities, including renal malformations that can progress to end‐stage renal disease (ESRD). Although rarely performed in patients with TS, renal transplantation offers significant benefits over dialysis. We report the case of a 34‐year‐old female with TS and ESRD who underwent a successful living‐donor kidney transplantation. Preoperative imaging revealed atrophic, malformed native kidneys located entirely in the pelvic region. A suitable graft bed was meticulously created in the right iliac fossa without the need for native nephrectomy. At the 9‐month postoperative follow‐up, the patient demonstrated excellent and stable graft function. This case highlights the feasibility of kidney transplantation in patients with TS and underscores the importance of careful preoperative planning and a multidisciplinary approach to overcome unique anatomical challenges.
Cellular senescence is a crucial process in aging and the pathogenesis of numerous diseases, including kidney diseases. As the kidney ages, the accumulation of senescent cells in renal tissues contributes to the progression of renal diseases such as chronic kidney disease (CKD) and fibrosis. Characterized by irreversible cell cycle arrest, these senescent cells secrete pro-inflammatory cytokines and extracellular matrix components through the senescence-associated secretory phenotype (SASP). This review investigates the molecular mechanisms underlying cellular senescence in the kidney, its impact on renal function, and its role in the development of renal pathologies. Understanding the interplay between aging and the development of renal disease offers valuable insights for the development of therapeutic strategies to slow or reverse renal aging and improve renal health.
Introduction: Interstitial cystitis (IC) is a chronic pelvic pain syndrome characterized by urinary urgency, frequency, and pain. Although the exact cause of IC is unclear, severe cases may lead to chronic kidney disease (CKD), requiring complex surgical interventions. Case Presentation: This case report presents a 46‐year‐old male with IC complicated by CKD secondary to total urethral stricture. Following recurrent surgeries for urinary tract infections and strictures, the patient underwent a staged surgical approach involving bilateral nephrectomy, supratrigonal cystectomy, and renal transplantation with Bricker ileal conduit diversion. Postoperatively, renal function was fully restored, and IC‐related symptoms resolved. Conclusion: This case underscores the efficacy of major surgical interventions for refractory IC, highlighting the need for individualized, multidisciplinary management in complex cases.
Introduction: Bardet–Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy characterized by multisystem involvement, with renal pathology, including end‐stage renal disease, being a major cause of morbidity and mortality. Case Presentation: This case report presents a 14‐year‐old boy with BBS and end‐stage renal disease who underwent a successful living donor kidney transplantation, marking the first reported case in Azerbaijan. Despite multiple comorbidities, including obesity, hypertension, and high panel reactive antibody levels, the patient achieved stable graft function with a rapid postoperative creatinine decline. Postoperative management focused on immunosuppression and lifestyle adjustments. Conclusion: This case contributes to the limited literature on BBS, highlighting both the challenges and favorable outcomes of renal transplantation in patients with this rare genetic disorder.
17 November 2024 in Urology Reports (St. - Petersburg)
BACKGROUND: Kidney transplantation is a recognized method of treating patients with end–stage kidney disease. However, the risk of graft loss is not excluded. In Azerbaijan, kidney transplantation is mainly performed from living donors; nevertheless, there is little data on the panel-reactive antibodies (PRA) and its use in the transplantation program. AIM: To evaluate the prevalence of positive panel-reactive antibodies (PRA) and short-term outcomes of living donor kidney transplantation. MATERIALS AND METHODS: Within 6 months after kidney transplantation, 113 recipients were followed up. All patients underwent their first transplantation. Complement-dependent cytotoxicity cross-matching, HLA typing, and flow cytometry cross-matching were carried out. Flow cytometric analysis was applied to detect PRA. The positive response percentage is presented by the percentage of events shifted to the right of the cutoff point. Data were analyzed using SPSS 16.0 statistical software. RESULTS: Among the examined patients, men predominated. In PRA-positive patients (n = 20), the dialysis duration was on average 22.3% longer than in PRA-negative patients (n = 93). 35.0% of PRA-positive patients had class I PRA, 30.0% of patients had class II PRA, and 35.0% had class I + II PRA. In 40.0% of cases, positive PRA had high sensitization 50% (predominantly class II), and the remaining 60.0% had PRA from 10% to 50%. Sensitizing factors were more common in the PRA-positive group (p 0.05). After 6 months of folow-up, the mean creatinine level was 183.4 ± 68.84 nmol/l in the PRA-positive group and 198.15 ± 108.23 nmol/l in the PRA-negative group (p = 0.91). The overall emptying rate was 4.4% (n = 5), with all 5 cases being in the PRA-negative group. No deaths were observed during the follow-up period. CONCLUSIONS: PRA positive patients usually have some sensitizing event such as pregnancy or blood transfusion. The transfusion itself was not a significant factor of sensitization in this study. Patients with high PRA levels require more thorough examination.